| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.400 | None | 0.956 | 203 | 8 | 1994 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2020 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2015 | 2018 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.100 | None | 0.882 | 17 | 0 | 2007 | 2020 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1998 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2016 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.400 | None | 0.923 | 91 | 6 | 1996 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.500 | None | 0.953 | 169 | 2 | 1995 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
group | 0.100 | None | 1.000 | 10 | 2 | 2011 | 2018 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
group | 0.100 | None | 0.962 | 52 | 1 | 2001 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.200 | None | 1.000 | 16 | 6 | 1998 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 2004 | 2019 | |||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 2007 | 2019 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 2009 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.100 | None | 0.952 | 21 | 3 | 1999 | 2020 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
group | 0.100 | None | 0.955 | 66 | 2 | 1995 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2001 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1998 | 2019 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2007 | 2019 |